Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Verrills

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Regional Anesthesia and Pain Medicine|March 20, 2024
First evidence of a biomarker-based dose-response relationship in chronic pain using physiological closed-loop spinal cord stimulationLeah Muller, Jason Pope, Paul Verrills, et al.
Pain Physician|February 4, 2025
Effects of Kilohertz Frequency on Paresthesia Perception Thresholds in Spinal Cord StimulationKas Amirdelfan, David Provenzano, Cong Yu, et al.
Pain Medicine (Malden, Mass.)|October 3, 2021
Pulse Dosing of 10-kHz Paresthesia-Independent Spinal Cord Stimulation Provides the Same Efficacy with Substantial Reduction of Device Recharge TimeDavid Provenzano, Jordan Tate, Mayank Gupta, et al.
Cureus|August 18, 2021
Results of a Pilot Study on the Safety and Early Efficacy of Novel Polymethyl Methacrylate Microspheres and a Hyaluronic Acid Device for the Treatment of Low Back Pain Caused by Degenerative and Diseased Intervertebral Discs of the Lumbar SpineJames Yu, William Taylor, Paul Verrills, et al.
Neuromodulation : Journal of the International Neuromodulation Society|June 11, 2022
Clinical Longevity of 106,462 Rechargeable and Primary Cell Spinal Cord Stimulators: Real World Study in the Medicare PopulationTimothy R Deer, Jason E Pope, Steven M Falowski, et al.
Future Science OA|June 6, 2022
Low-dose mesenchymal stem cell therapy for discogenic pain: safety and efficacy results from a 1-year feasibility studyDan Bates, David Vivian, Julien Freitag, et al.
Neuromodulation : Journal of the International Neuromodulation Society|May 15, 2013
A multicenter, prospective trial to assess the safety and performance of the spinal modulation dorsal root ganglion neurostimulator system in the treatment of chronic painLiong Liem, Marc Russo, Frank J P M Huygen, et al.
Neuromodulation : Journal of the International Neuromodulation Society|August 23, 2014
One-year outcomes of spinal cord stimulation of the dorsal root ganglion in the treatment of chronic neuropathic painLiong Liem, Marc Russo, Frank J P M Huygen, et al.
Journal of Pain Research|February 6, 2023
Best Practices from the American Society of Pain and Neuroscience (ASPN) for Clinical Research During a Pandemic or EmergencyErika A Petersen, Timothy R Deer, Stana Bojanic, et al.
Journal of Pain Research|January 26, 2024
Treating Chronic, Intractable Pain with a Miniaturized Spinal Cord Stimulation System: 1-Year Outcomes from the AUS-nPower Study During the COVID-19 PandemicJohn Salmon, Daniel Bates, Neels Du Toit, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Regional Anesthesia and Pain Medicine|March 20, 2024
First evidence of a biomarker-based dose-response relationship in chronic pain using physiological closed-loop spinal cord stimulationLeah Muller, Jason Pope, Paul Verrills, et al.
Pain Physician|February 4, 2025
Effects of Kilohertz Frequency on Paresthesia Perception Thresholds in Spinal Cord StimulationKas Amirdelfan, David Provenzano, Cong Yu, et al.
Pain Medicine (Malden, Mass.)|October 3, 2021
Pulse Dosing of 10-kHz Paresthesia-Independent Spinal Cord Stimulation Provides the Same Efficacy with Substantial Reduction of Device Recharge TimeDavid Provenzano, Jordan Tate, Mayank Gupta, et al.
Cureus|August 18, 2021
Results of a Pilot Study on the Safety and Early Efficacy of Novel Polymethyl Methacrylate Microspheres and a Hyaluronic Acid Device for the Treatment of Low Back Pain Caused by Degenerative and Diseased Intervertebral Discs of the Lumbar SpineJames Yu, William Taylor, Paul Verrills, et al.
Neuromodulation : Journal of the International Neuromodulation Society|June 11, 2022
Clinical Longevity of 106,462 Rechargeable and Primary Cell Spinal Cord Stimulators: Real World Study in the Medicare PopulationTimothy R Deer, Jason E Pope, Steven M Falowski, et al.
Future Science OA|June 6, 2022
Low-dose mesenchymal stem cell therapy for discogenic pain: safety and efficacy results from a 1-year feasibility studyDan Bates, David Vivian, Julien Freitag, et al.
Neuromodulation : Journal of the International Neuromodulation Society|May 15, 2013
A multicenter, prospective trial to assess the safety and performance of the spinal modulation dorsal root ganglion neurostimulator system in the treatment of chronic painLiong Liem, Marc Russo, Frank J P M Huygen, et al.
Neuromodulation : Journal of the International Neuromodulation Society|August 23, 2014
One-year outcomes of spinal cord stimulation of the dorsal root ganglion in the treatment of chronic neuropathic painLiong Liem, Marc Russo, Frank J P M Huygen, et al.
Journal of Pain Research|February 6, 2023
Best Practices from the American Society of Pain and Neuroscience (ASPN) for Clinical Research During a Pandemic or EmergencyErika A Petersen, Timothy R Deer, Stana Bojanic, et al.
Journal of Pain Research|January 26, 2024
Treating Chronic, Intractable Pain with a Miniaturized Spinal Cord Stimulation System: 1-Year Outcomes from the AUS-nPower Study During the COVID-19 PandemicJohn Salmon, Daniel Bates, Neels Du Toit, et al.
Pageof 5